MRK — Merck & Company, Inc. WATCH
Not on your watchlist — showing technicals/fundamentals only, no personal buy/sell targets.
| Price | 147.15 USD (≈€126.71) |
| Day change | 1.55% |
| Trend | downtrend |
| RSI(14) | nan |
| 52w range | 89.7% above low, -6.2% vs high |
| Sector | Healthcare / Drug Manufacturers - General |
| Trailing P/E | 115.9 |
| Revenue growth (yfinance) | 5.1% |
| Dividend yield | 2.35% |
| SEC-filed revenue | $64.2B (FY2024) → $65.0B (FY2025), 1.3% — SEC EDGAR ↗ |
Reasons
- 50-day average is below the 200-day average (downtrend) [yfinance]
- trailing P/E of 115.9 is high in absolute terms [yfinance]
- SEC-filed FY revenue growth (FY ending 2025-12-31): +1.3% [SEC EDGAR 10-K]
Price chart
Recent headlines
Informational only, not financial advice. Fictive portfolios use real market prices but no real money or broker.